Steady State Health Review
GLP-1 weight-loss telehealth · Independently scored 4.4/10
Best for: a published state list — 2 of 50 — when most of the register publishes none
Steady State Health's strongest column is disclosure — who oversees the prescribing and which pharmacy fills it.
Covered by the plan
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
$139/month is where clinical support starts, or $99/month if taken on its own; the drug itself is cash-pay, billed by whichever pharmacy dispenses it. Oregon and Washington are the two states covered. Josie Cowburn, DNP, FNP-C, a nurse practitioner, runs the women's-health practice, and its GLP-1 Metabolic Support program treats tirzepatide or semaglutide as part of a metabolic and hormone framework for menopause and perimenopause rather than a weight-loss drug standing alone.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to Steady State Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Steady State Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- What's included
- Consult
- Availability
- 2 states
- FDA status
- No FDA warning letter on record
How Steady State Health scores
Six columns, each one computed from something Steady State Health has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
3.0/10No monthly price is published at all, so value cannot be measured against the register. Capped rather than scored.
Effectiveness25%
5.0/10Publishes no medication list or price, so what is prescribed here cannot be established. Held at the midpoint — this is a gap in the record, not a finding about the drugs.
User Experience15%
5.0/10Where this seller first shows a price is not recorded yet, so the signup is unscored and sits at the midpoint.
Trust & Safety15%
6.0/10does not name a dispensing pharmacy; withholds price until after the intake; publishes its state list. Our verification confidence is high.
Accessibility10%
2.3/10Publishes coverage in 2 of 50 states.
Support10%
5.0/10No published price, so what a price would include cannot be assessed. Held at the midpoint.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on Steady State Health
Last checked July 2026- Checked state coverage: 2 states
- Established what the monthly figure covers, and what it leaves out
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: high.
GLP-1 medications Steady State Health offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
In its favor
- The monthly figure covers consult
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- Billed separately from the monthly figure: medication
- Coverage is published for 2 states only, so this may not reach you
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
What Steady State Health charges
Steady State Health does not publish a standing monthly price. That is a choice, and it means you cannot compare it against anything until you have gone through an intake and been quoted. When you get that quote, ask specifically for the ongoing monthly figure and what it includes — not the first-month rate, and not a program total divided by its length.
What Steady State Health dispenses
Steady State Health prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them.
What we could verify
On the record: it operates in 2 states. We searched the federal warning-letter record for this operator and came back with nothing. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to compare prices before committing time to an intake — there is no published figure to compare.
- You need to bill insurance. Like most of this market, this is cash-pay.
Our read
We cannot tell you whether Steady State Health is priced well, because it does not say. That is not automatically disqualifying — plenty of legitimate operators quote after intake — but it does mean the comparison has to happen after you have spent the time, which is the wrong order for the buyer. CoreAge Rx is the nearest comparison we track, and worth reading alongside this.
The Bottom Line
Steady State Health's strongest column is disclosure — who oversees the prescribing and which pharmacy fills it.
Before you pay Steady State Health
Check today's price, then book the free consultation.
Where Steady State Health is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Found.
- If you want a human checking in, not just a prescription, consider Oak.
- If your state is outside the area this one covers, consider Direct Meds.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Steady State Health review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
See Steady State Health's current pricing
The free consultation is where you learn whether you qualify, and what it costs today.